These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27823807)

  • 1. Electrophysiological assessment of Guillain-Barré syndrome with both Gal-C and ganglioside antibodies; tendency for demyelinating type.
    Samukawa M; Kuwahara M; Morikawa M; Ueno R; Hamada Y; Takada K; Hirano M; Mitsui Y; Sonoo M; Kusunoki S
    J Neuroimmunol; 2016 Dec; 301():61-64. PubMed ID: 27823807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features in Guillain-Barré syndrome with anti-Gal-C antibody.
    Samukawa M; Hamada Y; Kuwahara M; Takada K; Hirano M; Mitsui Y; Sonoo M; Kusunoki S;
    J Neurol Sci; 2014 Feb; 337(1-2):55-60. PubMed ID: 24289889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
    Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N
    J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiganglioside antibodies are associated with axonal Guillain-Barré syndrome: a Japanese-Italian collaborative study.
    Sekiguchi Y; Uncini A; Yuki N; Misawa S; Notturno F; Nasu S; Kanai K; Noto Y; Fujimaki Y; Shibuya K; Ohmori S; Sato Y; Kuwabara S
    J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):23-8. PubMed ID: 22010183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
    Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
    Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-ganglioside antibodies in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy in Chinese patients.
    Fan C; Jin H; Hao H; Gao F; Sun Y; Lu Y; Liu Y; Lv P; Cui W; Teng Y; Huang Y
    Muscle Nerve; 2017 Apr; 55(4):470-475. PubMed ID: 27464289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, electrophysiological subtypes and antiganglioside antibodies in childhood Guillain-Barré syndrome.
    Kannan MA; Ch RK; Jabeen SA; Mridula KR; Rao P; Borgohain R
    Neurol India; 2011; 59(5):727-32. PubMed ID: 22019659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
    Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
    Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-ganglioside antibodies and elevated CSF IgG levels in Guillain-Barré syndrome.
    Matà S; Galli E; Amantini A; Pinto F; Sorbi S; Lolli F
    Eur J Neurol; 2006 Feb; 13(2):153-60. PubMed ID: 16490046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When is facial diplegia regarded as a variant of Guillain-Barré syndrome?
    Kim JK; Oh SY; Sohn EH; Hong YH; Jun SM; Bae JS
    J Peripher Nerv Syst; 2015 Mar; 20(1):32-6. PubMed ID: 25975218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barré syndrome.
    Hiraga A; Kuwabara S; Ogawara K; Misawa S; Kanesaka T; Koga M; Yuki N; Hattori T; Mori M
    Neurology; 2005 Mar; 64(5):856-60. PubMed ID: 15753422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demyelinating Guillain-Barré syndrome recurs more frequently than axonal subtypes.
    Notturno F; Kokubun N; Sekiguki Y; Nagashima T; De Lauretis A; Yuki N; Kuwabara S; Uncini A
    J Neurol Sci; 2016 Jun; 365():132-6. PubMed ID: 27206890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-demyelinating, reversible conduction failure in Fisher syndrome and related disorders.
    Umapathi T; Tan EY; Kokubun N; Verma K; Yuki N
    J Neurol Neurosurg Psychiatry; 2012 Sep; 83(9):941-8. PubMed ID: 22767382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute motor axonal neuropathy after Mycoplasma infection: Evidence of molecular mimicry.
    Susuki K; Odaka M; Mori M; Hirata K; Yuki N
    Neurology; 2004 Mar; 62(6):949-56. PubMed ID: 15037698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
    Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
    Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reactive anti-galactocerebroside antibodies and Mycoplasma pneumoniae infections in Guillain-Barré syndrome.
    Ang CW; Tio-Gillen AP; Groen J; Herbrink P; Jacobs BC; Van Koningsveld R; Osterhaus AD; Van der Meché FG; van Doorn PA
    J Neuroimmunol; 2002 Sep; 130(1-2):179-83. PubMed ID: 12225900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Kuwahara M; Suzuki S; Takada K; Kusunoki S
    J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-ganglioside antibodies profile in Guillain-Barré syndrome: Correlation with clinical features, electrophysiological pattern, and outcome.
    Naik GS; Meena AK; Reddy BAK; Mridula RK; Jabeen SA; Borgohain R
    Neurol India; 2017; 65(5):1001-1005. PubMed ID: 28879885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure.
    Ogawa G; Kaida K; Kuwahara M; Kimura F; Kamakura K; Kusunoki S
    J Neuroimmunol; 2013 Jan; 254(1-2):141-5. PubMed ID: 23000056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.